{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?houseId=1&min-answer.questionFirstAnswered.=2019-07-15T15%3A05%3A34.967Z&hansardHeading=HIV+Infection%3A+Drugs", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?houseId=1&min-answer.questionFirstAnswered.=2019-07-15T15%3A05%3A34.967Z&hansardHeading=HIV+Infection%3A+Drugs", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?houseId=1&min-answer.questionFirstAnswered.=2019-07-15T15%3A05%3A34.967Z&_metadata=all&hansardHeading=HIV+Infection%3A+Drugs", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&houseId=1&min-answer.questionFirstAnswered.=2019-07-15T15%3A05%3A34.967Z&hansardHeading=HIV+Infection%3A+Drugs", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?houseId=1&min-answer.questionFirstAnswered.=2019-07-15T15%3A05%3A34.967Z&hansardHeading=HIV+Infection%3A+Drugs", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?houseId=1&min-answer.questionFirstAnswered.=2019-07-15T15%3A05%3A34.967Z&hansardHeading=HIV+Infection%3A+Drugs", "items" : [{"_about" : "http://data.parliament.uk/resources/1721993", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1721993/answer", "answerText" : {"_value" : "
Human immunodeficiency virus (HIV) is a priority for the Government, and we will commission a new plan to end new HIV transmissions within England by 2030. As part of our work in developing a new plan, we will explore options for ensuring equity and equal access to pre-exposure prophylaxis (PrEP) for all communities, including those across different risk, demographic, and geographic groups.\u202fWe will also explore opportunities to deliver PrEP in settings outside of sexual health services, to improve access and equity, including considering online PrEP provision and PrEP in pharmacies.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"} } , "answeringMemberConstituency" : {"_value" : "Gorton and Denton"} , "answeringMemberPrinted" : {"_value" : "Andrew Gwynne"} , "dateOfAnswer" : {"_value" : "2024-07-23", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "788"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-07-23T09:28:11.353Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-07-18", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "HIV Infection: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of making pre-exposure prophylaxis (PrEP) available (a) in pharmacies and (b) from an online service.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : "http://data.parliament.uk/members/5314", "tablingMemberConstituency" : {"_value" : "Brighton Pavilion"} , "tablingMemberPrinted" : [{"_value" : "Siân Berry"} ], "uin" : "782"} , {"_about" : "http://data.parliament.uk/resources/1721994", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1721994/answer", "answerText" : {"_value" : "
Human immunodeficiency virus (HIV) is a priority for the Government, and we will commission a new plan to end new HIV transmissions within England by 2030. As part of our work in developing a new plan, we will explore options for ensuring equity and equal access to pre-exposure prophylaxis (PrEP) for all communities, including those across different risk, demographic, and geographic groups.\u202fWe will also explore opportunities to deliver PrEP in settings outside of sexual health services, to improve access and equity, including considering online PrEP provision and PrEP in pharmacies.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"} } , "answeringMemberConstituency" : {"_value" : "Gorton and Denton"} , "answeringMemberPrinted" : {"_value" : "Andrew Gwynne"} , "dateOfAnswer" : {"_value" : "2024-07-23", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "782"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-07-23T09:28:11.417Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-07-18", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "HIV Infection: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure communities have equal access to pre-exposure prophylaxis (PrEP) across different (a) risk, (b) demographic and (c) geographic groups.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : "http://data.parliament.uk/members/5314", "tablingMemberConstituency" : {"_value" : "Brighton Pavilion"} , "tablingMemberPrinted" : [{"_value" : "Siân Berry"} ], "uin" : "788"} , {"_about" : "http://data.parliament.uk/resources/1716555", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1716555/answer", "answerText" : {"_value" : "
We remain committed to achieving equitable provision of HIV pre-exposure prophylaxis (PrEP) irrespective of gender, age, ethnicity, sexual orientation, disability, geographic area of residence, or socio-economic background. The HIV Action Plan Implementation Steering Group (ISG) published a roadmap in February 2024 to help guide efforts to improve access, uptake, and use of PrEP amongst key population groups at significant risk of HIV in England. An implementation working group of key delivery partners is being set up, which will monitor progress on actions and report back to the ISG.<\/p>
Devolved administrations are responsible for developing and implementing their own public health strategies. Colleagues in England meet regularly with their counterparts in the devolved administrations, to share information and best practice on our response to HIV, including provision of PrEP.<\/p>
Our commitment to PrEP as part of a combination approach is emphasised by our investment in the successful rollout of PrEP across England, where PrEP is routinely available in specialist sexual health services since March 2020, and we invested more than £34 million in PrEP in 2020/21 and 2021/22. PrEP funding has now been included within the Public Health Grant (PHG) since 2022/23, and funds appointments and testing in sexual health services, whilst NHS England covers the costs of the drug itself. The PHG is funded at £3.6 billion for 2024/25.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4117", "label" : {"_value" : "Biography information for Andrea Leadsom"} } , "answeringMemberConstituency" : {"_value" : "South Northamptonshire"} , "answeringMemberPrinted" : {"_value" : "Andrea Leadsom"} , "dateOfAnswer" : {"_value" : "2024-05-15", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-05-15T13:11:32.757Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-05-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "HIV Infection: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that PrEP is available in all parts of the UK.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4754", "label" : {"_value" : "Biography information for Peter Gibson"} } , "tablingMemberConstituency" : {"_value" : "Darlington"} , "tablingMemberPrinted" : [{"_value" : "Peter Gibson"} ], "uin" : "25354"} , {"_about" : "http://data.parliament.uk/resources/1680633", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1680633/answer", "answerText" : {"_value" : "
Data for 2023 is not yet available and is to be published in autumn of 2024. The following table shows the number of people in 2021 and 2022 who initiated or continued HIV pre-exposure prophylaxis (PrEP) at sexual health services (SHSs) in England in the past two years for the demographic groups requested, as well as the proportion among those with HIV PrEP need:<\/p>
<\/p><\/td> | 2021<\/p><\/td> | 2022<\/p><\/td><\/tr> |
England<\/p><\/td> | 61,510 (69.7%)<\/p><\/td> | 86,324(71.0%)<\/p><\/td><\/tr> |
Gay, bisexual and other men who have sex with men<\/p><\/td> | 51,689 (72.2%)<\/p><\/td> | 72,457 (73.5%)<\/p><\/td><\/tr> |
Women<\/p><\/td> | 1,237 (31.5%)<\/p><\/td> | 2,467 (41.9%)<\/p><\/td><\/tr> |
Black men (black African, black Caribbean and black other categories)<\/p><\/td> | 2,408 (61.7%)<\/p><\/td> | 2,986 (61.7%)<\/p><\/td><\/tr> |
Black women (black African, black Caribbean and black other categories)<\/p><\/td> | 80 (19.0%)<\/p><\/td> | 175 (30.2%)<\/p><\/td><\/tr><\/tbody><\/table> <\/p> More data is available at the following links:<\/p> https://www.gov.uk/government/statistics/hiv-annual-data-tables<\/a><\/p> |